Open Access Open Access  Restricted Access Subscription Access

Molecular Docking Analysis of Selected Natural Products from Plants for Inhibition of SARS-CoV-2 Main Protease


Affiliations
1 School of Ecology and Conservation, University of Agricultural Sciences, GKVK, Bengaluru 560 065, India
2 Indian Institute of Integrative Medicine, Council of Scientific and Industrial Research, Jammu 180 001, India
3 Department of Crop Physiology, University of Agricultural Sciences, GKVK, Bengaluru 560 065, India
 

In this article, we report results of a molecular docking analysis of commonly occurring natural product compounds against COVID-19 6LU7 and 6Y2E proteases. Our results show that several of these compounds have binding affinity against both the COVID-19 proteases, and compare well with a known anti-HIV drug, Saquinavir. Many of the compounds form an integral component of many cuisines, both Indian as well as others. We propose that some of these compounds could be easily and quickly positioned to hold fort against the COVID-19 virus, until of course newer therapies are discovered and detailed studies are taken to empirically validate some of the compounds for their ability to inhibit the virus.

Keywords

Affinity/Binding Energy, COVID-19 Protease, Drug Discovery, Ligands, Natural Products.
User
Notifications
Font Size


  • Molecular Docking Analysis of Selected Natural Products from Plants for Inhibition of SARS-CoV-2 Main Protease

Abstract Views: 410  |  PDF Views: 185

Authors

Megha Hastantram Sampangi-Ramaiah
School of Ecology and Conservation, University of Agricultural Sciences, GKVK, Bengaluru 560 065, India
Ram Vishwakarma
Indian Institute of Integrative Medicine, Council of Scientific and Industrial Research, Jammu 180 001, India
R. Uma Shaanker
Department of Crop Physiology, University of Agricultural Sciences, GKVK, Bengaluru 560 065, India

Abstract


In this article, we report results of a molecular docking analysis of commonly occurring natural product compounds against COVID-19 6LU7 and 6Y2E proteases. Our results show that several of these compounds have binding affinity against both the COVID-19 proteases, and compare well with a known anti-HIV drug, Saquinavir. Many of the compounds form an integral component of many cuisines, both Indian as well as others. We propose that some of these compounds could be easily and quickly positioned to hold fort against the COVID-19 virus, until of course newer therapies are discovered and detailed studies are taken to empirically validate some of the compounds for their ability to inhibit the virus.

Keywords


Affinity/Binding Energy, COVID-19 Protease, Drug Discovery, Ligands, Natural Products.

References





DOI: https://doi.org/10.18520/cs%2Fv118%2Fi7%2F1087-1092